The move to reclassify cannabis from a Schedule I to a Schedule III drug could spark new studies into pain, aging and women's health, Dr. Staci Gruber tells GBH's All Things Considered.
President Trump is expected to sign an order that would reschedule marijuana to a lower drug classification, according to two ...